- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharma
Actavis plc+ Add to Watchlist
ACT:US226.5900 USD 0.2800 0.12%
As of 18:40:02 ET on 08/28/2014.
Company Profile for Actavis plc (ACT)
Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.
Key Executives for Actavis plc (ACT)
|Paul M BisaroChairman||Brenton L Saunders "Brent"President/CEO|
|R Todd JoyceChief Financial Officer||Robert A Stewart "Bob"Chief Operating Officer|
|James C D'AreccaChief Accounting Officer||Charles M MayrChief Communications Ofcr:Global|
|Patrick J EaganChief Human Resources Ofcr:Global||William Meury "Bill"Exec VP:Commercial|
|Lisa M DefrancescoVP:Global Investor Relations|